Inhibition of OATP1B1-mediated uptake by macrolides

被引：0
|
作者：
Seithel, A
Mürdter, T
Fromm, MF
König, J
机构：
[1] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
535
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Long-lasting inhibition of OATP1B1-mediated hepatic uptake of pitavastatin by cyclosporine in human hepatocytes
    Kageyama, Michiharu
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM REVIEWS, 2016, 48 : 75 - 75
  • [2] Long-Lasting Inhibitory Effects of Saquinavir and Ritonavir on OATP1B1-Mediated Uptake
    Shitara, Yoshihisa
    Takeuchi, Kumiko
    Horie, Toshiharu
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3427 - 3435
  • [3] Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA
    Williamson, B.
    Soars, A. C.
    Owen, A.
    White, P.
    Riley, R. J.
    Soars, M. G.
    XENOBIOTICA, 2013, 43 (10) : 920 - 931
  • [4] Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport
    Wagner, Jonathan B.
    Ruggiero, Melissa
    Leeder, J. Steven
    Hagenbuch, Bruno
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (11) : 1192 - 1198
  • [5] OATP1B1-MEDIATED HEPATIC UPTAKE OF SN-38, AN ACTIVE METABOLITE OF IRINOTECAN, AND ITS INHIBITION BY UREMIC TOXINS IN HUMANS
    Fujita, K.
    Sugiura, T.
    Okumura, H.
    Umeda, S.
    Nakamichi, N.
    Sasaki, Y.
    Kato, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S32 - S32
  • [6] OATP1B1-Mediated Uptake of Statins, Estrone 3-sulfate and Estradiol 17β-glucuronide in HEK293-OATP1B1 Cells and Inhibition by Rifamycin SV, Gemfibrozil and an Investigational Drug
    Sharma, Pradeep
    Butters, Caroline J.
    Smith, Veronica
    Elsby, Robert
    Lawrence, Peter J.
    Surry, Dominic
    DRUG METABOLISM REVIEWS, 2010, 42 : 287 - 288
  • [7] Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38
    Mariko Iwase
    Ken-ichi Fujita
    Yuki Nishimura
    Natsumi Seba
    Yusuke Masuo
    Hiroo Ishida
    Yukio Kato
    Yuji Kiuchi
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 993 - 998
  • [8] Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38
    Iwase, Mariko
    Fujita, Ken-ichi
    Nishimura, Yuki
    Seba, Natsumi
    Masuo, Yusuke
    Ishida, Hiroo
    Kato, Yukio
    Kiuchi, Yuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 993 - 998
  • [9] IMPAIRED OATP1B1-MEDIATED TRANSPORT FOLLOWING TREATMENT WITH LYSOSOMOTROPIC DRUG CHLOROQUINE: IMPLICATIONS IN OATP-MEDIATED DRUGeDRUG INTERACTIONS
    Yue, Wei
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S12 - S12
  • [10] Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
    Wang, Hepeng
    Sun, Pengyuan
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    RSC ADVANCES, 2017, 7 (48): : 30038 - 30048
12345